Physician profile
Jerold James Olson
NPI 1881745354
$1,709.86
in general payments reported to CMS, 2019-2025
19 companies · $77.35 in 2025
The $77.35 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $388 · 2021: $112 · 2022: $191 · 2023: $260 · 2024: $88.06 · 2025: $77.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $216.04 | 2023-2025 | |
| Depuy Synthes Sales INC. | $203.59 | 2019-2023 | Trumatch |
| Regeneron Healthcare Solutions, INC. | $179.21 | 2019-2021 | |
| Stryker Corporation | $156.67 | 2019 | |
| Genzyme Corporation | $149.34 | 2019-2023 | |
| Leo Pharma INC. | $138.30 | 2020-2023 | Adbry |
| Integra Lifesciences Corporation | $96.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.03 | 2020-2021 | |
| Janssen Biotech, INC. | $80.35 | 2020-2022 | |
| Ucb, INC. | $73.95 | 2019-2020 | |
| Encore Dermatology INC. | $69.40 | 2019-2020 | |
| Genentech USA, INC. | $57.65 | 2019-2020 | |
| Amgen INC. | $49.91 | 2020 | |
| Allergan, INC. | $45.49 | 2021-2022 | |
| Kls-Martin L.P. | $24.88 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $22.58 | 2022 | |
| Mayne Pharma Commercial LLC | $18.35 | 2020 | |
| Merz North America, INC. | $17.07 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerold Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.